HansBiomed Balance Sheet Health
Financial Health criteria checks 5/6
HansBiomed has a total shareholder equity of ₩73.3B and total debt of ₩27.3B, which brings its debt-to-equity ratio to 37.3%. Its total assets and total liabilities are ₩120.7B and ₩47.4B respectively.
Key information
37.3%
Debt to equity ratio
₩27.30b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩7.24b |
| Equity | ₩73.27b |
| Total liabilities | ₩47.41b |
| Total assets | ₩120.68b |
Recent financial health updates
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Feb 29
Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?
Mar 06Recent updates
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Feb 29HansBiomed Corporation (KOSDAQ:042520) Shares Fly 25% But Investors Aren't Buying For Growth
Feb 29Are Dividend Investors Making A Mistake With HansBiomed Corporation (KOSDAQ:042520)?
Apr 10Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?
Mar 06HansBiomed's(KOSDAQ:042520) Share Price Is Down 63% Over The Past Three Years.
Jan 30Are HansBiomed's (KOSDAQ:042520) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Dec 08
Declining Stock and Decent Financials: Is The Market Wrong About HansBiomed Corporation (KOSDAQ:042520)?
Nov 20Financial Position Analysis
Short Term Liabilities: A042520's short term assets (₩50.3B) exceed its short term liabilities (₩42.7B).
Long Term Liabilities: A042520's short term assets (₩50.3B) exceed its long term liabilities (₩4.7B).
Debt to Equity History and Analysis
Debt Level: A042520's net debt to equity ratio (27.4%) is considered satisfactory.
Reducing Debt: A042520's debt to equity ratio has increased from 16.9% to 37.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A042520 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A042520 has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 22.9% each year.